Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.

He cited a 2019 study, which he claimed found that just a 5-ounce serving of french fries from a major fast-food chain fried ...

Throughout history, roses have been a powerful motif in love stories. A new wave of rose-infused fragrances is captivating a fresh generation, adding a modern twist to this timeless symbol.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today ...

Ever wondered why canned soda tastes different from one in a plastic bottle? Learn how container materials impact flavor.

Aldeyra's reproxalap faced an FDA setback but showed positive trial results, leading to a resubmitted NDA. Click here to find ...

Research analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Aldeyra Therapeutics in a ...

Humans may not be the only animals that ingest alcohol, research is suggesting. Studies on animals are showing they may be eating natural ethanol for its medicinal or nutritional properties.

Aldeyra Therapeutics, Inc.’s ALDX share price has dipped by 19.40%, which has investors questioning if this is right time to ...

Reproxalap, a first-in-class small-molecule modulator of reactive aldehyde species (RASP), is under review for the treatment of the signs and symptoms of dry eye disease. It works by covalently ...

Aldeyra Therapeutics (NASDAQ:ALDX – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Thursday, March 6th. Analysts expect the company to announce ...